07/11/2025
4:15 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2025
4:01 PM | Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2025
3:32 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/07/2025
3:10 PM | Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
4:34 PM | Keswani Sanjay Chandru (Reporting)
Neurocrine Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/04/2025
4:37 PM | Keswani Sanjay Chandru (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
5:15 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
5:15 PM | Neurocrine Biosciences (Issuer)
RASTETTER WILLIAM H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
4:26 PM | Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
4:28 PM | Neurocrine Biosciences (Issuer)
Sharp Shalini (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
4:29 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for NBIX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
05/22/2025
4:32 PM | Neurocrine Biosciences (Issuer)
POON CHRISTINE A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
4:12 PM | Mercier Johanna (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
4:14 PM | Neurocrine Biosciences (Issuer)
Norwalk Leslie V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
4:18 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
4:20 PM | MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
4:23 PM | Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
4:14 PM | Neurocrine Biosciences (Filer)
| Form S-8 POS | |
05/21/2025
4:16 PM | Neurocrine Biosciences (Filer)
| Form S-8 POS | |
05/21/2025
4:18 PM | Neurocrine Biosciences (Filer)
| Form S-8 POS | |
05/21/2025
4:19 PM | Neurocrine Biosciences (Filer)
| Form S-8 POS | |
05/21/2025
4:20 PM | Neurocrine Biosciences (Filer)
| Form S-8 POS | |
05/21/2025
4:22 PM | Neurocrine Biosciences (Filer)
| Form S-8 POS | |
05/21/2025
4:23 PM | Neurocrine Biosciences (Filer)
| Form S-8 POS | |
05/21/2025
4:24 PM | Neurocrine Biosciences (Filer)
| Form S-8 POS | |
05/21/2025
4:25 PM | Neurocrine Biosciences (Filer)
| Form S-8 POS | |
05/21/2025
4:26 PM | Neurocrine Biosciences (Filer)
| Form S-8 POS | |
05/21/2025
4:27 PM | Neurocrine Biosciences (Filer)
| Form S-8 POS | |
05/21/2025
4:28 PM | Neurocrine Biosciences (Filer)
| Form S-8 POS | |
05/21/2025
3:15 PM | Neurocrine Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/20/2025
3:43 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2025
6:05 PM | Neurocrine Biosciences (Issuer)
RASTETTER WILLIAM H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:40 PM | Neurocrine Biosciences (Subject)
RASTETTER WILLIAM H (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/28/2025
6:42 AM | BlackRock, Inc. (Filed by)
Neurocrine Biosciences (Subject)
| Form SCHEDULE 13G/A | |
04/09/2025
3:04 PM | Neurocrine Biosciences (Filer)
| Form DEF 14A | |
04/09/2025
3:06 PM | Neurocrine Biosciences (Filer)
| Form DEFA14A | |
04/04/2025
7:02 AM | Neurocrine Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2025
1:09 PM | Neurocrine Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
6:13 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:49 PM | Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:57 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump’s betrayal exposed (Ad) Trump’s Final Reset
Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now. Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma |
02/14/2025
5:35 PM | Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:42 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:13 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:20 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:26 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:00 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:03 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:08 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
3:33 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
3:33 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
3:33 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
3:34 PM | Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
3:34 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
3:34 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
3:34 PM | Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
3:35 PM | Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
3:35 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
3:35 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
3:36 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
3:36 PM | Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
3:36 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
3:37 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
3:37 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
3:37 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
3:37 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
3:38 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
3:38 PM | Neurocrine Biosciences (Subject)
SHERWIN STEPHEN A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2025
5:41 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
5:44 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
5:46 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
5:48 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
5:49 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
5:52 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
5:56 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
6:00 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
3:51 PM | Neurocrine Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/06/2025
3:04 PM | Neurocrine Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
5:50 AM | Neurocrine Biosciences (Subject)
STATE STREET CORP (Filed by)
| Form SCHEDULE 13G | |
02/04/2025
5:05 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:42 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:45 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:47 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:49 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:51 PM | Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:54 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:58 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:31 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:35 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:19 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
3:32 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Tax Drain Deadline: Protect Your Wealth Before September 15th (Ad) On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers.
But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies.
American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained. Click here to download the guide and protect your assets before Sept 15th. |
01/31/2025
3:32 PM | Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
3:33 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
3:34 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
3:29 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
3:27 PM | Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
3:28 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
3:28 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
3:28 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
3:29 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
MarketBeat All Access